Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
6
Mins
27 Jun 2025
Critical Management of Neurocysticercosis with Hydrocephalus
Neurocysticercosis, a parasitic brain infection caused by the larvae of Taenia solium that leads to cysts in the central nervous system…
27 Jun 2025
Minimally Invasive Treatment for Benign Prostatic Hyperplasia
Importantly, 30% mean reductions in prostate volume were sustained up to 18 months post-procedure.
Sun Pharma appoints Richard Ascroft as North American CEO
Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.
27 Jun 2025
Can Microbiome-Guided Therapy Improve Cystic Fibrosis Outcomes?
A new international trial has investigated the safety and efficacy of tailoring antibiotic treatment for cystic fibrosis exacerbations based on sputum microbiome analysis.
27 Jun 2025
Combined Therapy for Allergic Rhinitis Shows Superior Results
The combination therapy demonstrated a significantly higher response rate (98.28%) compared to loratadine alone (87.93%).
4
Mins
26 Jun 2025
Mitigating the Treatment Gap in Drug-Resistant Epilepsy
For this article, EMJ conducted an interview with Ahmed Abdelmoity, Professor and Director, Division of Neurology, Children’s Mercy…
June 2025
EMJ Neurology 13 [Supplement 7] 2025
Interview article with Prof. Abdelmoity, discussing the current treatment landscape for patients with drug-resistant epilepsy (DRE)…
26 Jun 2025
New Technique Improves Recovery After Liver Surgery
A recent prospective study explored the effectiveness of using indocyanine green to improve intraoperative detection of bile leakage.
US withdraws funding from Gavi, the Vaccine Alliance
The US plans to stop its financial contributions to Gavi, the Vaccine Alliance, marking an end to an over 20-year partnership.
26 Jun 2025
AI Achieves High Accuracy in Automated Echocardiogram Interpretation
AI now matches experts in echocardiogram interpretation, promising faster, more accessible heart diagnostics for all patients.
←
1
2
3
4
5
…
1,155
1,156
1,157
→
We’ve noticed you’re accessing
from
North/South America.
View
View